ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Docetaxel and Oxaliplatin as First-Line Therapy for Advanced Non-Small Cell Lung Cancer: A Phase II Trial
Journal of Chemotherapy
◽
10.1179/joc.2009.21.4.439
◽
2009
◽
Vol 21
(4)
◽
pp. 439-444
◽
Cited By ~ 4
Author(s):
A. Radhakrishnan
◽
J.D. Bitran
◽
D.T. Milton
◽
K. Tolzien
◽
S. Hallmeyer
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Related Documents
Cited By
References
Randomized, Multi-center Phase II Trial of Docetaxel Plus Cisplatin Versus Etoposide Plus Cisplatin as the First-line Therapy for Patients with Advanced Non-Small Cell Lung Cancer
Cancer Research and Treatment
◽
10.4143/crt.2005.37.6.332
◽
2005
◽
Vol 37
(6)
◽
pp. 332
Author(s):
Nam-Su Lee
◽
Hee-Sook Park
◽
Jong-Ho Won
◽
Dae-Sik Hong
◽
Su-Taek Uh
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Phase-II trial of taxotere (TXT) and Navelbine (N) as first-line therapy in patients (PTS) with advanced non-small cell lung cancer (ANSCLC)
Lung Cancer
◽
10.1016/s0169-5002(99)90743-2
◽
1999
◽
Vol 25
◽
pp. S19-S20
Author(s):
M. O'Rourke
◽
D. Garfield
◽
P. Ellis
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Phase II Trial of Irinotecan plus Cisplatin Combination as First Line Therapy for Patients with Small cell Lung Cancer
Tuberculosis and Respiratory Diseases
◽
10.4046/trd.2006.60.1.57
◽
2006
◽
Vol 60
(1)
◽
pp. 57
◽
Cited By ~ 1
Author(s):
Hye Cheol Jeong
◽
Sang Yeub Lee
◽
Jung Ha Kim
◽
Eun Sil Ha
◽
Jin Yong Jung
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Phase II trial of the multi-targeted antifolate LY231514 (MTA) as first-line therapy for patients with advanced non-small cell lung cancer (NSCLC)
European Journal of Cancer
◽
10.1016/s0959-8049(97)85830-3
◽
1997
◽
Vol 33
◽
pp. S231
◽
Cited By ~ 4
Author(s):
J. Rusthoven
◽
E. Eisenhauer
◽
C. Butts
◽
R. Gregg
◽
J. Dancey
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Preliminary safety results of a phase II trial comparing two schedules of lapatinib (GW572016) as first line therapy for advanced or metastatic non-small cell lung cancer
Journal of Clinical Oncology
◽
10.1200/jco.2005.23.16_suppl.7099
◽
2005
◽
Vol 23
(16_suppl)
◽
pp. 7099-7099
◽
Cited By ~ 8
Author(s):
H. J. Ross
◽
G. R. Blumenschein
◽
A. Dowlati
◽
J. Aisner
◽
J. R. Rigas
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
P2-295: Phase II trial a 2-h infusion of Gemcitabine-carboplatin combination as first-line therapy for stage IIIB or IV non-small cell lung cancer
Journal of Thoracic Oncology
◽
10.1097/01.jto.0000284003.11512.a7
◽
2007
◽
Vol 2
(8)
◽
pp. S689-S690
Author(s):
Bárbara M. Parente
◽
Fernando Barata
◽
Ana Fernandes
◽
Encarnação Teixeira
◽
Teresa Almodovar
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Randomised Phase II Study of Axitinib or Bevacizumab Combined with Paclitaxel/Carboplatin (PAC/CARB) as First-Line Therapy for Patients (PTS) with Advanced Non–Small Cell Lung Cancer (NSCLC)
Annals of Oncology
◽
10.1016/s0923-7534(20)33840-0
◽
2012
◽
Vol 23
◽
pp. ix408
Author(s):
C. Twelves
◽
E. Chmielowska
◽
L. Havel
◽
S. Popat
◽
A. Swieboda-Sadlej
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Study
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Phase II Study of Irinotecan Plus Cisplatin as First Line therapy in Extensive Small-Cell Lung Cancer
Tuberculosis and Respiratory Diseases
◽
10.4046/trd.2006.61.2.143
◽
2006
◽
Vol 61
(2)
◽
pp. 143
Author(s):
Ki Eun Hwang
◽
So Young Kim
◽
Jong Hoon Jung
◽
Seong Hoon Park
◽
Jung Hyun Park
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Study
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Phase II trial of docetaxel and gefitinib as first-line therapy for elderly patients with advanced non-small cell lung cancer (ANSCLC)
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.90140.7342
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7342-7342
Author(s):
C. C. Williams
◽
E. B. Haura
◽
S. J. Antonia
◽
A. Chiappori
◽
G. Bepler
◽
...
Keyword(s):
Lung Cancer
◽
Elderly Patients
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer
Annals of Oncology
◽
10.1093/annonc/mdu384
◽
2014
◽
Vol 25
(11)
◽
pp. 2156-2162
◽
Cited By ~ 19
Author(s):
S. Novello
◽
B. Besse
◽
E. Felip
◽
F. Barlesi
◽
J. Mazieres
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Randomized Study
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close